Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for Dengue Patients With Hyperinflammation
NCT05611710Phase 2Active, not recruiting
- Sponsor
- Oxford University Clinical Research Unit
- Start
- Jan 2023
- Primary completion
- Oct 2025
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dengue fever comparing Placebo with Anakinra (2 arms). Primary endpoint: Change in modified Sequential Organ Failure Assessment score at day 4. Started Jan 2023; status: active, not recruiting.
02
Drugs
anakinra
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT05611710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05611710.